A phase II randomized study evaluating the safety and efficacy of ABT-510 in subjects with locally advanced or metastatic soft tissue sarcoma

Trial Profile

A phase II randomized study evaluating the safety and efficacy of ABT-510 in subjects with locally advanced or metastatic soft tissue sarcoma

Completed
Phase of Trial: Phase II

Latest Information Update: 01 Nov 2008

At a glance

  • Drugs ABT 510 (Primary)
  • Indications Sarcoma; Soft tissue sarcoma
  • Focus Therapeutic Use
  • Most Recent Events

    • 01 Nov 2008 Results published in the Journal of Clinical Oncology.
    • 20 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top